How big is INmune Bio, Inc.?

Jun 22 2025 06:12 PM IST
share
Share Via
As of Jun 18, INmune Bio, Inc. has a market capitalization of 159.46 million and reported net sales of 0.05 million with a net profit of -40.80 million over the last four quarters. Shareholder's funds were 32.10 million, and total assets were 39.56 million as of Dec 24.
Market Cap: As of Jun 18, INmune Bio, Inc. has a market capitalization of 159.46 million, classified as a Micro Cap.

Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 0.05 million and a net profit of -40.80 million.

Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 32.10 million, while total assets were reported at 39.56 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is INmune Bio, Inc. technically bullish or bearish?
Sep 20 2025 08:03 PM IST
share
Share Via
Is INmune Bio, Inc. technically bullish or bearish?
Jun 25 2025 09:01 AM IST
share
Share Via
What does INmune Bio, Inc. do?
Jun 22 2025 06:59 PM IST
share
Share Via